Connect with us


Pfizer shows that its research and development is powerful. It makes the stock a good long-term bet.



Chief Scientific Officer Michael Dorsten sounded dazzled when contacted by phone early Monday morning. It was only a few days later that his company kicked socks out of the market with news that Covid-19 antivirals reduced the risk of hospitalization for high-risk adults by 89%.

“It’s not just random to be able to break this kind of world record and get a grand slam by chance at the same time,” Dorsten said, while scrambling the sports metaphor, Pfizer’s two victories: only 10? A surprisingly effective Covid-19 vaccine was developed in the month, and a year later, a similarly amazing Covid-19 antiviral drug was developed.

Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to make a big bet on the R & D business that Dorsten had rebuilt over a decade. The bet looks smarter than ever.

Bourla has abolished Pfizer’s unpatented pharmaceutical division and the last consumer health product, leaving a pure biopharmacy company that uses the power of Dorsten’s science to decide whether to live or die.

of November 2019 cover story, Barron’s Bourla and Dorsten claimed they could pull it off.

New antiviral data from Pfizer Barron’s Made two years ago. However, continuing to benefit from pandemics poses new risks as criticism of global inequality in vaccine distribution grows. Low-income countries account for less than 1% of the more than 7 billion doses administered worldwide. If Pfizer’s antiviral distribution continues to favor wealthy countries, company stocks can eventually suffer.

Pfizer’s share price surged 10.9% on the day the data was released, marking the highest daily in at least 20 years. Still, current stock prices are changing at around $ 50, and investors continue to underestimate the company. Investors have set Pfizer’s price at 12 times the expected earnings next year, which is cheaper than its peers.

Johnson & Johnson

(JNJ) and

Eli Lilly


Pfizer’s discounts could be due to concerns about the patent cliffs that pharmaceutical companies face at the end of the decade. The company will lose the monopoly on a handful of drugs that generate billions of dollars in annual revenue.

The worries are justified, but Pfizer’s scientific coup should give investors confidence that the company’s science can safely overcome the cliff. It may take some time for the market to catch up, but it is a promising opportunity for long-term investors.

The success of antivirals is the best ever example of Pfizer’s scientific capabilities.

While Pfizer’s Covid-19 vaccine emerged from the German biotechnology lab


(BNTX), a new Covid-19 antiviral, was launched by what Dorsten called the “dream team” of scientists in Pfizer’s own lab in the northeastern United States.

In the early days of the pandemic, Pfizer split its efforts between working with BioNTech on vaccines and the quest for Covid-19 pills. Vaccine efforts have been carried out on a large scale. Dorsten called it a “megateam” across the Atlantic.

The antiviral project was a much smaller undertaking. A group of Pfizer experts was working with the resources left behind in the promotion of the vaccine.

“Small molecules were like an agile, laser-focused, high-end team with fairly modest resources,” says Dollsten.

Dorsten has brought together some of Pfizer’s most experienced scientists to work on an antiviral project that includes Charlotte Alerton, who is responsible for its medical design. Scientists began with a study that Pfizer did a few years ago on a type of antiviral drug. Called a protease inhibitor..

However, Pfizer library protease inhibitors were given intravenously and did not work well when given orally. The team needed to understand how to adapt the drug to oral administration. This is a lot of work.

“They really had to create a lot of new chemistry,” Dorsten said. Scientists have created 600 compounds to identify the right drug. This process can usually take years and was completed in a few months. “Here, four years are now four months,” he said.

Pfizer began testing pills on humans in March. Currently, Phase 2/3 of the drug, including those targeted at high-risk patients, those targeted at non-high-risk patients, those exposed to the virus but not exposed to the virus, etc. We carry out many tests. I’m still sick.On the first read, the drug appeared to be substantially more effective than the Covid remedy from.



“It definitely helps to prove that point. [Pfizer’s] Pharmaceutical research and development is better than people thought, “said Louise Chen, an analyst at Cantor Fitzgerald.

Chen says investors aren’t expecting to get closer to her thinking until the durability of the sale of Covid-19 vaccines and pills becomes clearer and the rest of the pipeline is proven.

“There is no event that I think will trigger a stock revaluation at the next level,” she says. “I don’t think it will happen until they work.”

It makes betting on Pfizer a long-term play.In the meantime, experience


(MRNA) Over the last few weeks, vaccine manufacturers have highlighted the possibility of scrutiny of unequal distribution of vaccines.

Biden administration officials are increasingly frustrated with Modana and are calling on companies to increase production so that they can offer higher doses to low-income countries at non-profit prices. One chief executive is calling on the company to “step up.”

Moderna’s share has declined by more than 40% in the last three months.

As the pandemic continues, Pfizer risks damaging the enormous credit gained when it introduced the Covid-19 vaccine about a year ago. Earlier this month, Pfizer CEO Bourla said low-income countries blamed the unfair distribution of vaccines. Barron’s It was their fault that they didn’t order. Pfizer is selling a billion doses of vaccine to the United States at a non-profit price to donate to poor countries, with at least two billion doses of vaccine next year.

When it comes to antivirals, Pfizer only states that it will offer gradual pricing to poor countries with the same approach adopted for vaccines.

This is in contrast to Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a contract with a UN-backed group. This allows pills to be licensed globally without paying royalties to Merck.

According to Dorsten, Pfizer is considering licensing tablets using a mechanism similar to Merck. “We will consider those options,” he said. “We never said we would do anything different. We just want to ensure that the people involved have the advice and skills to do this.”

Such a step could not come immediately. At the end of last month, activists protested outside Bourla’s house, calling on Pfizer to share vaccine-making technology and accept orders from low-income countries rather than wealthy ones.

Aggressive plans to share that antiviral will help stop such criticism, keep Pfizer in Washington’s relatively good grace, and allow its impressive science to continue to grow inventories. ..

Write in Josh Nathan-Kazis at [email protected]





The mention sources can contact us to remove/changing this article

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos


to request, modification Contact us at Here or [email protected]